PIERIS PROTEOLAB AG has a total of 33 patent applications. Its first patent ever was published in 1997. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology and pharmaceuticals are INHIBRX LP, ARGEN-X N V and DAVIES JULIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Australia | 4 | |
#4 | United States | 4 | |
#5 | Canada | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | Germany | 1 | |
#9 | Hong Kong | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Skerra Arne | 27 |
#2 | Schlehuber Steffen | 17 |
#3 | Vogt Martin | 6 |
#4 | Fiedler Markus | 4 |
#5 | Arne Skerra | 3 |
#6 | Steffen Schlehuber | 3 |
#7 | Beste Gerald | 2 |
#8 | Stibora Thomas Dr | 1 |
#9 | Steffen Skerra Arne Schlehuber | 1 |
#10 | Poehlchen Martin | 1 |
Publication | Filing date | Title |
---|---|---|
WO2005097994A1 | Digoxigenin-binding muteins of the bilin-binding protein of pieris brassicae | |
AU2003275958A1 | Muteins of tear lipocalin | |
AU2003264100A1 | Muteins of a bilin-binding protein with affinity for a given target | |
AU2002368307A1 | Soluble truncated polypeptides of the nogo-a protein | |
US7118915B2 | Muteins of apolipoprotein D | |
WO03029462A1 | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins | |
DE19742706A1 | lipocalin muteins |